The Clinical Trial Equipment & Ancillary Solutions Market was valued at USD 2.23 billion in 2023 and is expected to reach USD 4.39 billion by 2032, expanding at a CAGR of 7.84% over the forecast period 2024-2032. The market’s growth is being fueled by the increasing number of clinical trials worldwide, advancements in trial technologies, and the...